Silvia Arifi

Goethe University Frankfurt

Publishes on Nuclear Receptors and Signaling, Computational Drug Discovery Methods, Peroxisome Proliferator-Activated Receptors. 11 papers and 249 citations.

PubIndex Score80Top 20% · early-careerHow it's scored

11Publications

249Total Citations

First publication: 2019

Nuclear Receptors and Signaling Computational Drug Discovery Methods Peroxisome Proliferator-Activated Receptors Organic Chemistry Cycloaddition Reactions Retinoids in leukemia and cellular processes

Top publicationsby citations

The Medicinal Chemistry of Caffeine

Giuseppe Faudone, Daniel Merk, Silvia Arifi|Journal of Medicinal Chemistry|2021

Cited by 116

<scp>l</scp>-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ

Leonie Gellrich, Daniel Merk, Pascal Heitel et al.|Journal of Medicinal Chemistry|2020

Cited by 49

Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ Modulation

Silvia Arifi, Daniel Merk, Laura Isigkeit et al.|Journal of the American Chemical Society|2023

Cited by 49

Druggability Evaluation of the Neuron Derived Orphan Receptor (NOR‐1) Reveals Inverse NOR‐1 Agonists

Daniel Zaienne, Daniel Merk, Silvia Arifi et al.|ChemMedChem|2022

Cited by 11

Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency

Gustave Adouvi, Daniel Merk, Felix Nawa et al.|Journal of Medicinal Chemistry|2023

Cited by 10